Patients Know Best has secured new funding from Harbert European Growth Capital Fund II (“HEGCF II”) to support its rapid business growth.
Harbert European Growth Capital is a leading provider of growth capital that invests in high-growth technology companies throughout Europe.
Patients Know Best (PKB) is already used in more than 60 hospitals in the UK, the Netherlands and Germany. This investment will be used to accelerate revenue growth in the UK and overseas.
Dr Mohammad Al-Ubaydli, who founded the company in 2008, said: “This represents a new era for Patients Know Best. We have the best patient portal on the market and evidence from one of the most advanced and stringent healthcare systems in the world – the UK’s National Health Service – showing the success of our approach. We are delighted to be working with a partner of the calibre of Harbert. This investment will help us to go further, faster by expanding our team and developing our digital platform to transform global healthcare services at scale and pace.”
Fahad Khan, Vice President Harbert European Growth Capital, said: “We are delighted to support one of the most disruptive solutions simplifying a complex healthcare industry. The growth potential of PKB is beyond any doubt, and we are very pleased to be part of its future and hope to bring our close relationships within the technology sector to the fore”.
Lyall Davenport, Harbert European Growth Capital, added: “We are excited by PKB’s potential to transform the way that patients manage their personal data and monitor their healthcare needs, we believe that their platform will empower patients throughout the UK and we are looking forward to working with Mohammad, Ian and the PKB team going forward”.